Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Summary: The purpose of this study was to perform a review of the longitudinal studies to determine whether polycystic ovary syndrome is associated with higher prevalence of metabolic complications and cardiovascular morbidity and mortality. The primary outcomes included body mass index, metabolic syndrome and its components (waist circumference, lipid profile, arterial hypertension, abnormal glucose metabolism (impaired fasting glucose, impaired glucose tolerance, type 2 diabetes), insulin resistance, and cardiovascular diseases like stroke, angina, and coronary heart disease. Complications in pregnant women were beyond the scope of this review. PubMed database (1992‐2018) was searched to identify proper publications. Finally, data from 47 articles were analysed. Studies differed in the design (prospective, retrospective, cohort, observational), research methods, polycystic ovary syndrome diagnostic criteria, studied populations, race, and ethnicity of the participants. Based on the data collected, it appears that women with polycystic ovary syndrome have higher prevalence of obesity, abdominal fat distribution, dyslipidaemia and deterioration of glucose metabolism, but increased prevalence of cardiovascular diseases is not proven.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 21×
“Similarly, Morgan et al noted a substantially increased risk for the development of T2DM in young women with PCOS (mean age 27.1 years)—respective rates equalled 5.7 per 1000 patient‐year in PCOS and 1.7 in controls, with a relative‐risk ratio of 3.12.97 Incidence rates of T2DM in PCOS per 1000 person‐years totalled 3…”
BackgroundInfluentialAmenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976 · cited 2×
“In the 21st century, authors still emphasized that long‐lasting metabolic dysfunction in women with PCOS could exaggerate CVD risk and probably lead to an increase in CV events with age, especially after menopause.(11,62,63) Wild et al estimated that PCOS women with obesity, cigarette smoking, dyslipidaemia, AH, IGT,…”
BackgroundDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360 · cited 1×
“In the 21st century, authors still emphasized that long‐lasting metabolic dysfunction in women with PCOS could exaggerate CVD risk and probably lead to an increase in CV events with age, especially after menopause.(11,62,63) Wild et al estimated that PCOS women with obesity, cigarette smoking, dyslipidaemia, AH, IGT,…”
BackgroundPrevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257 · cited 4×
“In the 90s, Ehrmann et al noted that women with PCOS whose glucose tolerance deteriorated had significantly higher BMI than the rest of the cohort.(66) Two years later, Norman et al considered baseline BMI as an independent significant predictor of adverse change in glycaemic control – it was counted that overweight a…”
BackgroundMethodResultInfluentialMoran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010 · cited 1×
“Wild et al estimated that PCOS women with obesity, cigarette smoking, dyslipidaemia, AH, IGT, and subclinical vascular disease are at moderate risk for developing CVD, whereas patients with MetS or T2DM are at high risk.(40) The recommendations were elaborated to screen women with PCOS for CVD risk factors.”
BackgroundWild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970 · cited 6×
“Significantly higher levels of TG in PCOS than in controls were observed in several European studies.(76,80,82,83) Serum level of TG in early adulthood was described by Ollila et al as significant risk factor for PCOS later in life.”
BackgroundResultInfluentialLim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · cited 1×
“In women with PCOS, higher levels of very low‐density lipoprotein cholesterol and low‐density lipoprotein cholesterol (LDL‐C) were also described,(38-41) with predominantly small dense LDL‐C particles, which are considered to have special atherogenic potential.(42,43) One of the most often cited articles concerning ab…”
BackgroundMuka, T., Oliver-Williams, C., Kunutsor, S., Laven, J. S. E., Fauser, B. C. J. M., Chowdhury, R., Kavousi, M., & Franco, O. H. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2415 · Cited by 826
International Diabetes Federation: a consensus on Type 2 diabetes prevention
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02157.x · Cited by 778
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1329 · Cited by 703
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Low grade chronic inflammation in women with polycystic ovarian syndrome
Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7580 · Cited by 640
Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome
Legro, R. S., Kunselman, A. R., & Dunaif, A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00948-2 · Cited by 622
Menstrual cycle irregularity and risk for future cardiovascular disease
Solomon, C. G., Hu, F. B., Dunaif, A., Rich-Edwards, J. E., Stampfer, M. J., Willett, W. C., Speizer, F. E., & Manson, J. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8471 · Cited by 528
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504 · cited 4×
“Mortality Most of the authors found similar total mortality in PCOS women and controls.(80,85,97,104,105) Contrary results were obtained by Hart et al, who noticed significantly higher all‐cause mortality among PCOS women in comparison with controls—0.”
BackgroundResultInfluentialThe Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
Hart, R., & Doherty, D. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3886 · Cited by 391 · cited 6×
“2%.(86) Additionally, Merz et al observed a trend toward more prevalent multivessel CHD in postmenopausal women with PCOS (P = .”
BackgroundInfluentialVgontzas, A. N., Legro, R. S., Bixler, E. O., Grayev, A., Kales, A., & Chrousos, G. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7185 · Cited by 371
Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus
Solomon, C. G. (2001) · JAMA · doi:10.1001/jama.286.19.2421 · Cited by 362 · cited 2×
“Concurrently, Solomon et al described that crude rates of T2DM in women with OM equalled 84 and 839 per 100 000 person‐years respectively among lean and overweight/obese cases.(95) Authors from Turkey recently noticed a 4‐fold increased risk of IGT or T2DM in obese PCOS women.”
BackgroundResultTeede, H. J., Joham, A. E., Paul, E., Moran, L. J., Loxton, D., Jolley, D., & Lombard, C. (2013) · Obesity · doi:10.1002/oby.20213 · Cited by 351 · cited 23×
“Similarly, Morgan et al noted a substantially increased risk for the development of T2DM in young women with PCOS (mean age 27.1 years)—respective rates equalled 5.7 per 1000 patient‐year in PCOS and 1.7 in controls, with a relative‐risk ratio of 3.12.97 Incidence rates of T2DM in PCOS per 1000 person‐years totalled 3…”
BackgroundResultInfluentialNorman, R. J., Masters, L., Milner, C. R., Wang, J. X., & Davies, M. J. (2001) · Human Reproduction · doi:10.1093/humrep/16.9.1995 · Cited by 341 · cited 5×
“On the other hand, authors of several longitudinal studies demonstrate that the risk of T2DM in women with PCOS is linked mainly to overweight, to obesity, or to weight gain through the life.(66,74,92,101,103) Similar results were achieved by Pelanis et al, who in a Nordic cross‐sectional study found that no normal‐we…”
BackgroundResultInfluentialLauritsen, M. P., Bentzen, J. G., Pinborg, A., Loft, A., Forman, J. L., Thuesen, L. L., Cohen, A., Hougaard, D. M., & Nyboe Andersen, A. (2014) · Human Reproduction · doi:10.1093/humrep/det469 · Cited by 334
Complications and challenges associated with polycystic ovary syndrome: current perspectives
Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s70314 · Cited by 287
Overweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease
Meyer, C., McGrath, B. P., & Teede, H. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0011 · Cited by 273 · cited 1×
“However, few studies in which 24‐ hour ambulatory blood pressure (BP) monitoring was used did not show any difference between PCOS women and controls.(51,52) Interestingly, publications regarding elevated levels of inflammatory markers(53,54) and high frequency of subclinical vascular disease in PCOS have increasingly…”
BackgroundSchmidt, J., Landin-Wilhelmsen, K., Brännström, M., & Dahlgren, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1677 · Cited by 241 · cited 10×
“A progressive, significant rise in waist circumference WC in PCOS women was observed in an Italian study, in which controls were not followed.78 Significantly greater WC was found by the group of researchers from Finland in women with PCOS compared with controls, both at ages 31 and 46.79 Surprisingly, no significant…”
BackgroundMethodResultInfluentialCardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Glintborg, D., Rubin, K. H., Nybo, M., Abrahamsen, B., & Andersen, M. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0680-5 · Cited by 200 · cited 1×
“2 per 1000 person‐years.(108) Moreover, incidence rate of CVD excluding AH and dyslipidaemia was estimated at 6.”
BackgroundOllila, M.-M. E., Piltonen, T., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., & Morin-Papunen, L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3543 · Cited by 182 · cited 3×
“In the recently published prospective population‐ based study, Ollila et al noticed that weight gain was significantly greater in women with PCOS compared with controls, and that PCOS was significantly associated with BMI at all studied ages.(79) Additionally, it was emphasized that the change in BMI only in early adu…”
ResultInfluentialOllila, M.-M. E., West, S., Keinänen-Kiukaanniemi, S., Jokelainen, J., Auvinen, J., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dew329 · Cited by 165 · cited 2×
“45).(103) There were also emphasized no association between PCOS and the risk of prediabetes, and noticeable synergistic effect between PCOS and BMI in the developing T2DM.”
BackgroundResultGlintborg, D., Hass Rubin, K., Nybo, M., Abrahamsen, B., & Andersen, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1108 · Cited by 154 · cited 1×
“Similarly, Glintborg et al in a register‐based study of over 57 000 patients observed higher prevalence of AH in women with PCOS than in controls, with 2 times higher prescription of the antihypertensive medications.(50) However, few studies in which 24‐ hour ambulatory blood pressure (BP) monitoring was used did not…”
BackgroundPolycystic Ovary Syndrome and Risk for Long-Term Diabetes and Dyslipidemia
Wang, E. T., Calderon-Margalit, R., Cedars, M. I., Daviglus, M. L., Merkin, S. S., Schreiner, P. J., Sternfeld, B., Wellons, M., Schwartz, S. M., Lewis, C. E., et al. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31820209bb · Cited by 146 · cited 8×
“Cibula et al reported no significant differences among PCOS and controls,(88) though Wang et al noticed that PCOS was associated with 2‐fold higher odds of dyslipidaemia over 18 years, independently of BMI.(93) Pasquali et al did not find any significant changes in lipids in Italian PCOS women during over 10 years.”
BackgroundResultInfluentialRacial and ethnic differences in the polycystic ovary syndrome metabolic phenotype
Engmann, L., Jin, S., Sun, F., Legro, R. S., Polotsky, A. J., Hansen, K. R., Coutifaris, C., Diamond, M. P., Eisenberg, E., Zhang, H., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.01.003 · Cited by 144 · cited 3×
“Chan et al in a cross‐sectional study found that black women from the United States had over 4 times higher odds of the prevalence of MetS than US white women after age adjustment.122 However, hypertriglyceridemia was found significantly less frequent in black women both by Chan et al122 and Engmann et al.121 The know…”
BackgroundInfluentialGoverde, A. J., van Koert, A. J. B., Eijkemans, M. J., Knauff, E. A. H., Westerveld, H. E., Fauser, B. C. J. M., & Broekmans, F. J. (2008) · Human Reproduction · doi:10.1093/humrep/den433 · Cited by 135
Patel, S. M., Ratcliffe, S. J., Reilly, M. P., Weinstein, R., Bhasin, S., Blackman, M. R., Cauley, J. A., Sutton-Tyrrell, K., Robbins, J., Fried, L. P., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0740 · Cited by 132
Orio, F., Muscogiuri, G., Nese, C., Palomba, S., Savastano, S., Tafuri, D., Colarieti, G., La Sala, G., Colao, A., & Yildiz, B. O. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.08.026 · Cited by 126
Schmidt, J., Brännström, M., Landin-Wilhelmsen, K., & Dahlgren, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2959 · Cited by 113 · cited 1×
“Conversely, Schmidt et al observed an increase in WHR in both studied groups, but much higher in controls, that led to a decline in the significant difference of WHR observed in the beginning of the study.(84) Several authors reported significantly greater BMI in PCOS women than in controls.”
ResultGlueck, C. J., Dharashivkar, S., Wang, P., Zhu, B., Gartside, P. S., Tracy, T., & Sieve, L. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.03.010 · Cited by 99
Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome
Berneis, K., Rizzo, M., Hersberger, M., Rini, G. B., Di Fede, G., Pepe, I., Spinas, G. A., & Carmina, E. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01897.x · Cited by 94
Merz, C. N. B., Shaw, L. J., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2016) · Journal of Women's Health · doi:10.1089/jwh.2015.5441 · Cited by 87 · cited 3×
“Mortality Most of the authors found similar total mortality in PCOS women and controls.(80,85,97,104,105) Contrary results were obtained by Hart et al, who noticed significantly higher all‐cause mortality among PCOS women in comparison with controls—0.”
BackgroundResultKazemi Jaliseh, H., Ramezani Tehrani, F., Behboudi-Gandevani, S., Hosseinpanah, F., Khalili, D., Cheraghi, L., & Azizi, F. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.09.004 · Cited by 80
Hudecova, M., Holte, J., Olovsson, M., Larsson, A., Berne, C., & Sundstrom-Poromaa, I. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.08.006 · Cited by 61
Karabulut, A., Yaylali, G. F., Demirlenk, S., Sevket, O., & Acun, A. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.589929 · Cited by 61
Cited by
Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women
O’Kelly, A. C., Michos, E. D., Shufelt, C. L., Vermunt, J. V., Minissian, M. B., Quesada, O., Smith, G. N., Rich-Edwards, J. W., Garovic, V. D., El Khoudary, S. R., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319895 · Cited by 328
Polak, A. M., Adamska, A., Krentowska, A., Łebkowska, A., Hryniewicka, J., Adamski, M., & Kowalska, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030732 · Cited by 48
Self-citationIs polycystic ovary syndrome a 20th Century phenomenon?
Rodgers, R. J., Suturina, L., Lizneva, D., Davies, M. J., Hummitzsch, K., Irving-Rodgers, H. F., & Robertson, S. A. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.01.019 · Cited by 34
“Women with PCOS have at least a four-fold increased risk of type 2 diabetes, even without taking into account their additional predisposition to becoming overweight [5,6].”
BackgroundActkins, K. V., Singh, K., Hucks, D., Velez Edwards, D. R., Aldrich, M., Cha, J., Wellons, M., & Davis, L. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa675 · Cited by 27
Zhuang, J., Wang, Y., Wang, S., Hu, R., & Wu, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-64849-0 · Cited by 23
Metadata
- Authors
- Jacewicz‐Święcka, M., & Kowalska, I.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2018-09-19
- Volume
- 34
- Issue
- 8
- Pages
- e3054-e3054
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2887200820
- Cited by
- 38
- References
- 49
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.